IL17A and pulmonary fibrosis: In LC, elevated IL‐17 levels have moreover been correlated with pre‐existing hypertension, suggesting a complex interaction between chronic post‐COVID manifestations, including pulmonary fibrosis, and pre‐existing health conditions [53, 54].